The results obtained in the present experiment are presented as below.
Sero-biochemistry
The concentration of BUN and serum creatinine (mg/dl) in group 2 (96.81 ± 0.11 and 1.49 ± 0.035, Respectively) was significantly (P < 0.05) higher when compared to non toxic groups 14th day, while treatment groups 5 (53.13 ± 0.12 and 0.88 ± 0.017, Respectively) and 6 (52.98 ± 0.14 and 0.83 ± 0.014, Respectively) showed significantly (P < 0.05) lower values in comparison to group 2 (Table 2).
Antioxidant profile
The concentration of GSH (nm/mg) revealed a significant (P < 0.05) decrease in toxic control group 2 (17.41±0.12) when compared to non toxic groups, whereas treatment groups 5 and 6 (28.54 ± 0.18 and 28.95 ± 0.17, respectively) revealed a significant (P<0.05) improvement as compared to toxic control group 2 (Table 2).
The concentration of TBARS and protein carbonyls (nm/mg) revealed a significant (P < 0.05) increase in toxic control group 2 (18.18 ± 0.12 and 9.71 ± 0.09) when compared to non toxic groups, whereas treatment groups 5 (12.54 ± 0.08 and 5.97 ± 0.10, Respectively) and 6 (12.23 ± 0.23 and 6.08 ± 0.16, Respectively) showed significantly (P < 0.05) lower values in comparison to group 2 (Table 2).
Cytokine profile
The concentration of TNF-α and IL-10 (pg/mg tissue) revealed a significant (P < 0.05) increase in toxic control group 2 (22.35 ± 0.24 and 14.95 ± 0.26, Respectively) when compared to non toxic groups, whereas treatment groups 5 (11.04 ± 0.21and 12.06 ± 0.21, Respectively) and 6 (11.11 ± 0.17 and 12.23 ± 0.19, Respectively) showed significantly (P < 0.05) lower values in comparison to group 2 (Table 3).
Histopathology
Normal histology of the rat kidney tissue was found in the non toxic groups (Fig 1). Renal tissue sections from rats treated with cisplatin showed moderate variations in glomerular structure (Fig 2), mild increase in bowman’s space with significant shrinkage of some glomerular tufts, degenerations in glomerular capsule and mononuclear cell infiltration with moderate peritubular inflammation (Fig 3). The kidney tissue sections of the cisplatin treated rats exhibited marked acute tubular necrosis and marked dilation and degenerations of tubules and vacuolation (Fig 4), whereas rats treated with TA justified the protective action by minimizing the inflammation of mononuclear cells, tubular necrosis (Fig 5) and by showing mild tubular degenerative changes (Fig 6). Renal histology in taurine treated group showed mild infiltration of inflammatory cells (Fig 7) and congestion (Fig 8).
The present study was conducted on 3 month old
Wistar rats for a period of 14 days to evaluate the protective role of TA and taurine against cisplatin induced nephrotoxicity. The biochemical markers, oxidative stress and cytokines were assessed. Histopathology of kidney tissues were conducted to draw possible conclusions at the end of the experiment. The increase in kidney biomarkers is observed in toxic group due to exposure to cisplatin is a function of the overall balance between the degree of oxidative stress and the antioxidant capability
(Hosseinian et al., 2016). Rashed et al., (2011) also reported the elevation of serum creatinine and BUN following cisplatin injection. This is a clear indication of renal toxicity caused by cisplatin as the markers are released by the damaged kidney into circulatory system. In the study of
Sherif (2015), administration of TA had a protective effect leading to improvement in renal function as indexed by marked decline in serum creatinine and BUN in comparison to cisplatin group. Marked recovery was observed in the markers after treatment with TA and taurine The antioxidant system is responsible primarily for defense against ROS, and the formation and elimination of ROS in the cells is accomplished by the radical scavenging system, which includes GSH, TBARS and protein carbonyls
(Ekinci akdemir et al., 2017). Karimi et al., (2018) reported increased MDA levels and decreased GSH levels in cases of cisplatin induced toxicity. Oxidative stress caused by cisplatin induced excessive production of ROS leads to peroxidation of membrane lipids and depletion of antioxidant enzymes. NADPH oxidase is an enzyme system, which enhances cisplatin mediated ROS generation and cytotoxicity
(El Sawalhi and Ahmed, 2014). Lipid peroxidation causes glomerular injury, increases fluidity and permeability of tubular membranes and triggers hypertrophy of renal tubules
(Al kahtani et al., 2014). The natural antioxidant arjunolic acid was shown to improve cisplatin induced nephrotoxicity via significant enhancement of antioxidant activity of renal GSH and significant reduction of renal MDA levels
(Sherif, 2015; Elsherbiny et al., 2016). Our findings revealed that TA and taurine administration increased GSH levels, suppressed the increase in MDA and protein carbonyls concentration observed in cisplatin group.
Inflammation plays a crucial role in the pathogenesis of cisplatin induced nephrotoxicity
(Zhang et al., 2007). TNF-α plays a key role in mediating the inflammatory injury in cisplatin-induced toxicity
(Yousef and Hussien, 2015). Concurrent with the induction of a stress-activated inflammatory response, many agents with anti-inflammatory properties are generated that may inhibit tissue damage
(Deng et al., 2001). IL-10 is a multifunctional anti-inflammatory cytokine that has been reported to attenuate different renal pathologies
(Kitching et al., 2002). TA and taurine at the doses administered significantly normalized the elevated levels of inflammatory cytokines and thus protected the kidney from inflammatory insult.
These results are further substantiated from histopathology, which revealed normal histology of a rat kidney tissue found in control group. However, histopathology of renal tissue sections from rats treated with cisplatin alone showed shrunken glomeruli, mononuclear cell infiltration, including acute tubular necrosis and marked dilation of proximal convoluted tubules. The cisplatin-induced histological alterations are in agreement with previous studies
(Athira et al., 2016 and
Malik et al., 2016). TA and taurine administration for 14 days significantly improved the cisplatin induced histological changes and showed minimum tubular damage, less necrotic damage and less accumulation of inflammatory cells.